Eric J. Buenz
Mayo Clinic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eric J. Buenz.
American Journal of Pathology | 2009
Eric J. Buenz; Brian M. Sauer; Reghann G. LaFrance-Corey; Chandra Deb; Aleksandar Denic; Christopher L. German; Charles L. Howe
Many viruses, including picornaviruses, have the potential to infect the central nervous system (CNS) and stimulate a neuroinflammatory immune response, especially in infants and young children. Cognitive deficits associated with CNS picornavirus infection result from injury and death of neurons that may occur due to direct viral infection or during the immune responses to virus in the brain. Previous studies have concluded that apoptosis of hippocampal neurons during picornavirus infection is a cell-autonomous event triggered by direct neuronal infection. However, these studies assessed neuron death at time points late in infection and during infections that lead to either death of the host or persistent viral infection. In contrast, many neurovirulent picornavirus infections are acute and transient, with rapid clearance of virus from the host. We provide evidence of hippocampal pathology in mice acutely infected with the Theilers murine encephalomyelitis picornavirus. We found that CA1 pyramidal neurons exhibited several hallmarks of apoptotic death, including caspase-3 activation, DNA fragmentation, and chromatin condensation within 72 hours of infection. Critically, we also found that many of the CA1 pyramidal neurons undergoing apoptosis were not infected with virus, indicating that neuronal cell death during acute picornavirus infection of the CNS occurs in a non-cell-autonomous manner. These observations suggest that therapeutic strategies other than antiviral interventions may be useful for neuroprotection during acute CNS picornavirus infection.
Scientific Reports | 2012
Charles L. Howe; Reghann G. LaFrance-Corey; Rhianna Sundsbak; Brian M. Sauer; Stephanie J. LaFrance; Eric J. Buenz; William F. Schmalstieg
Neuronal injury during acute viral infection of the brain is associated with the development of persistent cognitive deficits and seizures in humans. In C57BL/6 mice acutely infected with the Theilers murine encephalomyelitis virus, hippocampal CA1 neurons are injured by a rapid innate immune response, resulting in profound memory deficits. In contrast, infected SJL and B6xSJL F1 hybrid mice exhibit essentially complete hippocampal and memory preservation. Analysis of brain-infiltrating leukocytes revealed that SJL mice mount a sharply attenuated inflammatory monocyte response as compared to B6 mice. Bone marrow transplantation experiments isolated the attenuation to the SJL immune system. Adoptive transfer of B6 inflammatory monocytes into acutely infected B6xSJL hosts converted these mice to a hippocampal damage phenotype and induced a cognitive deficit marked by failure to recognize a novel object. These findings show that inflammatory monocytes are the critical cellular mediator of hippocampal injury during acute picornavirus infection of the brain.
BMJ | 2006
Eric J. Buenz; Brent A. Bauer; Holly E Johnson; Gaugau Tavana; Eric M Beekman; Kristi L. Frank; Charles L. Howe
Historical herbal texts provide a window for resurrecting lost knowledge, and “mining” of these texts can lead to the identification of new drugs
Cytometry Part A | 2007
Eric J. Buenz; Paul J. Limburg; Charles L. Howe
Apoptosis plays a role in many disease states, and the evaluation of novel therapeutics that alters the apoptotic cascade is an area of intense investigation. However, many generally available methods to evaluate cell death are either time consuming, imprecise, or both. We report a system that permits simultaneous evaluation of three apoptotic markers (cell membrane integrity, mitochondrial membrane potential, and cell cycle progression) with minimal technical manipulation. This system is particularly well‐suited for toxicologic evaluation of novel compounds and profiling of new apoptosis‐inducing agents.
Scientific Reports | 2016
Charles L. Howe; Reghann G. LaFrance-Corey; Kanish Mirchia; Brian M. Sauer; Renee M. McGovern; Joel M. Reid; Eric J. Buenz
Neurologic complications associated with viral encephalitis, including seizures and cognitive impairment, are a global health issue, especially in children. We previously showed that hippocampal injury during acute picornavirus infection in mice is associated with calpain activation and is the result of neuronal death triggered by brain-infiltrating inflammatory monocytes. We therefore hypothesized that treatment with a calpain inhibitor would protect neurons from immune-mediated bystander injury. C57BL/6J mice infected with the Daniel’s strain of Theiler’s murine encephalomyelitis virus were treated with the FDA-approved drug ritonavir using a dosing regimen that resulted in plasma concentrations within the therapeutic range for calpain inhibition. Ritonavir treatment significantly reduced calpain activity in the hippocampus, protected hippocampal neurons from death, preserved cognitive performance, and suppressed seizure escalation, even when therapy was initiated 36 hours after disease onset. Calpain inhibition by ritonavir may be a powerful tool for preserving neurons and cognitive function and preventing neural circuit dysregulation in humans with neuroinflammatory disorders.
Experimental Biology and Medicine | 2006
Eric J. Buenz
A number of traditional medicine plants are hepatotoxic. Thus, while the traditional uses of Atuna racemosa suggest little indication for toxicity, it is nonetheless important to examine the potential for this extract to target the liver. Using Jurkat T cells and HepG2 hepatocytes as a model, the potential hepatotoxicity of this extract was evaluated. The results of a conditioned media experiment suggest that A. racemosa extract would likely be detoxified by the liver. These results provide the necessary background to Initiate an in vivo toxicology investigation.
Journal of Ethnopharmacology | 2005
Eric J. Buenz; Brent A. Bauer; T. W. Osmundson; Timothy J. Motley
Trends in Pharmacological Sciences | 2004
Eric J. Buenz; David J. Schnepple; Brent A. Bauer; Peter L. Elkin; John M. Riddle; Timothy J. Motley
Trends in Microbiology | 2006
Eric J. Buenz; Charles L. Howe
Journal of Ethnopharmacology | 2005
Eric J. Buenz; H.E. Johnson; Eric M Beekman; Timothy J. Motley; Ben Bauer